U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07284693) titled 'Phenolic Complex k110-42 Therapy on Cognitive Functions in Down Children' on Nov. 30.

Brief Summary: The goal of this study is to evaluate the efficacy of phenolic complex k110-42 on cognitive function of children with Down syndrome

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: Cognitive Functions

Intervention: DRUG: Phenolic complex k110-42

900 mg/kg once oral in form of sachet for 6 month

DRUG: Neumentix

0 mg/kg once sachet oral for 6 month

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Mansoura University

Information provided by (Responsible Party): Haidi Sameh Ahmed Elassal, Mansoura University...